Total Payments
$8,661
2024 Payments
$4,001
Companies
64
Transactions
428
Medicare Patients
599
Medicare Billing
$72,363
Payment Breakdown by Category
Food & Beverage$8,433 (97.4%)
Education$227.49 (2.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,433 | 423 | 97.4% |
| Education | $227.49 | 5 | 2.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $709.82 | 39 | $0 (2024) |
| Janssen Biotech, Inc. | $573.18 | 33 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $568.70 | 30 | $0 (2024) |
| Incyte Corporation | $445.15 | 15 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $433.86 | 24 | $0 (2024) |
| PFIZER INC. | $409.40 | 25 | $0 (2024) |
| Daiichi Sankyo Inc. | $387.36 | 15 | $0 (2024) |
| Gilead Sciences, Inc. | $360.92 | 15 | $0 (2024) |
| Genentech USA, Inc. | $302.37 | 16 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $278.15 | 22 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,001 | 201 | Merck Sharp & Dohme LLC ($336.51) |
| 2023 | $3,441 | 187 | Merck Sharp & Dohme LLC ($280.30) |
| 2022 | $911.20 | 37 | BeiGene USA, Inc. ($134.13) |
| 2021 | $226.41 | 2 | Incyte Corporation ($226.41) |
| 2019 | $80.48 | 1 | Pharmacyclics LLC, An AbbVie Company ($80.48) |
All Payment Transactions
428 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | ABBVIE INC. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $18.85 | General |
| Category: ONCOLOGY | ||||||
| 12/19/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $21.50 | General |
| 12/19/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: ONCOLOGY | ||||||
| 12/18/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $27.07 | General |
| Category: ONCOLOGY | ||||||
| 12/18/2024 | Genentech USA, Inc. | Lunsumio (Biological) | Food and Beverage | In-kind items and services | $16.25 | General |
| Category: BioOncology | ||||||
| 12/17/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: ONCOLOGY | ||||||
| 12/13/2024 | PFIZER INC. | IBRANCE (Drug), TUKYSA | Food and Beverage | In-kind items and services | $29.34 | General |
| Category: ONCOLOGY | ||||||
| 12/11/2024 | Lilly USA, LLC | VERZENIO (Drug), JAYPIRCA | Food and Beverage | In-kind items and services | $21.72 | General |
| Category: Oncology | ||||||
| 12/10/2024 | Kite Pharma, Inc. | Yescarta (Drug) | Food and Beverage | In-kind items and services | $16.04 | General |
| Category: CELLT | ||||||
| 12/09/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $18.80 | General |
| Category: Oncology | ||||||
| 12/06/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: Oncology | ||||||
| 12/05/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $24.37 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 12/02/2024 | Stemline Therapeutics Inc. | ELZONRIS (Drug) | Food and Beverage | In-kind items and services | $27.14 | General |
| Category: Oncology | ||||||
| 12/02/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $21.09 | General |
| Category: ONCOLOGY | ||||||
| 11/25/2024 | Coherus Biosciences Inc. | Udenyca (Biological), LOQTORZI | Food and Beverage | In-kind items and services | $20.78 | General |
| Category: Granulocyte colony stimulating factor | ||||||
| 11/22/2024 | AstraZeneca Pharmaceuticals LP | ENHERTU (Biological) | Food and Beverage | In-kind items and services | $16.70 | General |
| Category: Oncology | ||||||
| 11/21/2024 | ARRAY BIOPHARMA INC | LORBRENA (Drug), BRAFTOVI, MEKTOVI | Food and Beverage | In-kind items and services | $18.17 | General |
| Category: ONCOLOGY | ||||||
| 11/18/2024 | TerSera Therapeutics LLC | Zoladex (Drug) | Food and Beverage | In-kind items and services | $20.18 | General |
| Category: Oncology | ||||||
| 11/17/2024 | Exelixis Inc. | CABOMETYX (Drug) | Food and Beverage | In-kind items and services | $14.21 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 11/13/2024 | Bayer Healthcare Pharmaceuticals Inc. | Stivarga (Drug), Vitrakvi, Nubeqa | Food and Beverage | In-kind items and services | $16.26 | General |
| Category: Oncology | ||||||
| 11/11/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $24.01 | General |
| 11/09/2024 | Genentech USA, Inc. | Columvi (Biological) | Food and Beverage | In-kind items and services | $19.90 | General |
| Category: BioOncology | ||||||
| 11/07/2024 | AstraZeneca Pharmaceuticals LP | ENHERTU (Biological) | Education | In-kind items and services | $25.95 | General |
| Category: Oncology | ||||||
| 11/07/2024 | Genentech USA, Inc. | Itovebi (Biological), Tecentriq Hybreza | Food and Beverage | In-kind items and services | $23.18 | General |
| Category: BioOncology | ||||||
| 11/07/2024 | GlaxoSmithKline, LLC. | OJJAARA (Drug) | Food and Beverage | In-kind items and services | $19.94 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 476 | 855 | $169,847 | $61,897 |
| 2022 | 3 | 123 | 132 | $27,025 | $10,466 |
Total Patients
599
Total Services
987
Medicare Billing
$72,363
Procedure Codes
11
All Medicare Procedures & Services
11 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 228 | 577 | $109,630 | $40,140 | 36.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 68 | 68 | $17,748 | $6,312 | 35.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 103 | 126 | $16,254 | $5,840 | 35.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 43 | 43 | $15,222 | $5,571 | 36.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 18 | 24 | $6,216 | $2,255 | 36.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 16 | 17 | $4,777 | $1,781 | 37.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 33 | 37 | $7,030 | $2,742 | 39.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 26 | 26 | $6,786 | $2,655 | 39.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 32 | 36 | $6,840 | $2,594 | 37.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 16 | 16 | $4,176 | $1,617 | 38.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 16 | 17 | $2,193 | $858.16 | 39.1% |
About Dr. Christopher Burkeen, MD
Dr. Christopher Burkeen, MD is a Hematology & Oncology healthcare provider based in Lexington, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/29/2016. The National Provider Identifier (NPI) number assigned to this provider is 1225490253.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Burkeen, MD has received a total of $8,661 in payments from pharmaceutical and medical device companies, with $4,001 received in 2024. These payments were reported across 428 transactions from 64 companies. The most common payment nature is "Food and Beverage" ($8,433).
As a Medicare-enrolled provider, Burkeen has provided services to 599 Medicare beneficiaries, totaling 987 services with total Medicare billing of $72,363. Data is available for 2 years (2022–2023), covering 11 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Lexington, KY
- Active Since 03/29/2016
- Last Updated 07/11/2019
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1225490253
Products in Payments
- KEYTRUDA (Biological) $670.65
- JAKAFI (Drug) $402.07
- Enhertu (Drug) $339.71
- LIBTAYO (Biological) $235.73
- DARZALEX (Biological) $231.63
- BRUKINSA (Drug) $195.37
- Trodelvy (Drug) $194.87
- OPDIVO (Biological) $191.93
- Lenvima (Drug) $186.07
- OJJAARA (Drug) $177.34
- REBLOZYL (Biological) $168.61
- IMBRUVICA (Drug) $167.03
- IBRANCE (Drug) $144.53
- TAGRISSO (Drug) $144.52
- ULTOMIRIS (Biological) $128.93
- VENCLEXTA (Drug) $118.94
- XTANDI (Drug) $114.83
- ERLEADA (Drug) $107.78
- SCEMBLIX (Drug) $104.83
- ENHERTU (Biological) $102.17
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Lexington
Dr. Nicola Jabbour, M.d, M.D
Hematology & Oncology — Payments: $611,455
Hematology & Oncology $611,455
Dr. Lowell Anthony, M.d, M.D
Hematology & Oncology — Payments: $64,060
Hematology & Oncology $64,060
Dr. Zhonglin Hao, Md, Phd, MD, PHD
Hematology & Oncology — Payments: $22,675
Hematology & Oncology $22,675
John Villano
Hematology & Oncology — Payments: $17,051
Hematology & Oncology $17,051
Dr. Jessica Croley, Md, MD
Hematology & Oncology — Payments: $13,189
Hematology & Oncology $13,189
Mr. Russell Eldridge, Md, MD
Hematology & Oncology — Payments: $10,781
Hematology & Oncology $10,781